...years. For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location and other criteria, go to www.inc.com/inc5000. More about...
...you think. In this advisory brief, we outline the top five things to keep in mind if you are considering a switch. Please complete the form to download a copy...
...a CCO’s responsibilities, resources and expectations. Future issues will offer advice from peers and experts on launch planning and hiring. To learn more, contact us at info@trinitylifesciences.com. Download White Paper...
...success in 2023. Download this white paper to understand: The five key market access trends emanating from 2022 that foretell the opportunities and challenges that lie ahead in 2023 (and...
...Companies reached out to TGaS Advisors for our guidance in navigating this uncharted territory, and we stepped up to proactively support more than 1,800 individuals across 300 partner companies. The...
...access may be mainly dictated by country-level agreements. Please complete the form to download a copy of our Trinity Whitepaper: How Monoclonal Antibodies Can Help in the Fight Against the...
...factors that drove this dichotomy? Please complete the form to download a copy of our Trinity Whitepaper – The 2020 Dichotomy: An Analysis of the COVID-19 Launch Class and How...
...•How aware are companies of the pending changes? •What are organizations doing to mitigate the impact? Please complete the form to download a copy of our Advisory Brief: Changes in...
Gene therapies’ single administration nature presents a unique commercial challenge for biopharmaceutical companies; unlike traditional small molecule or biologic therapies that can be dosed chronically or repeatedly on an “as...
...DTx might evolve in the future. Download this white paper to understand: The current requirements for DTx coverage in the U.S. Perspectives from payers about the future of DTx coverage...
